BIG DEAL | HIV FUNDING CRISIS: Nigeria Faces Imminent Treatment Breakdown as Donor Support Shrinks

Experts warn Nigeria’s HIV response could collapse within months as donor cuts threaten treatment continuity, leaving 1.9 million citizens at risk and exposing deep vulnerabilities in health financing, policy, and stigma protection.

Nigeria’s Human Immunodeficiency Virus (HIV) response is at a critical crossroads, with experts warning that shrinking donor support could trigger a nationwide treatment crisis within months, risking decades of progress.

The Association of Community Pharmacists of Nigeria (ACPN) and Civil Society for HIV/AIDS in Nigeria (CiSHAN) warned during World AIDS Day 2025 that overdependence on external donors, particularly the United States, jeopardises Nigeria’s long-term HIV response sustainability.

They called for immediate investment in local drug manufacturing, more substantial policy commitments, and leadership to prevent service disruptions and ensure sustainable access to HIV treatment.

Key Intelligence Highlights

Funding Collapse Risk: ACPN Chairman Ambrose Ezeh warned that reduced international support threatens the continuity of HIV treatment, prevention, and care nationwide.

National Burden: Nigeria recorded 1,400 new infections and 50,000 AIDS-related deaths weekly in 2023, with 1.9 million citizens currently living with HIV.

Treatment Innovation Needed: Experts urged adoption of long-acting antiretrovirals (Cabotegravir, Rilpivirine) and broader access to PrEP, which offers up to 96% protection for high-risk groups.

Community Integration: Pharmacists and civil society leaders emphasised deeper integration of community pharmacies for testing, counselling, and treatment continuity.

CiSHAN pressed Kogi State to pass its HIV Anti-Stigma Bill, highlighting that legal protections can foster a more inclusive environment, ensuring care-seeking and disclosure are supported, and stigma is reduced.

State-Level Vulnerability: Kogi alone has 50,000 people living with HIV, with 19,000 not accessing care. Anambra reported 80,258 cases in 2025, down from 93,000 in 2024, but prevalence remains high among key populations.

Global Context: UNAIDS reports donor cuts are disrupting services worldwide, leaving millions vulnerable. Nigeria’s reliance on external funding places its HIV response at immediate risk of collapse.

Strategic Implications

National Security Threat: A breakdown in HIV treatment continuity could destabilise communities, overwhelm health systems, and erode workforce productivity.

Policy Imperative: Experts insist Nigeria must urgently reconstitute weak state-level HIV boards, establish dedicated budget lines, and prioritise local manufacturing of antiretrovirals, diagnostics, and consumables.

Societal Impact: Rising stigma, discrimination, and lack of legal protections threaten to undo progress, while vulnerable populations remain at heightened risk of illness, exclusion, and transmission.

Intelligence Assessment

The warnings from ACPN and CiSHAN mark a turning point in Nigeria’s HIV response, which is shifting from donor-driven survival to a test of domestic resilience.

Without immediate government action — including financing reforms, legal safeguards, and investment in local production — the country risks a national health emergency with far-reaching social and economic consequences.